Churchill Downs Incorporated ( NASDAQ:CHDN ) just released its quarterly report and things are looking bullish. Results...

Unveiling the Strengths and Challenges: A Deep Dive into Churchill Downs Inc (CHDN) SWOT Analysis

Boyd Gaming's (BYD) second-quarter 2024 results benefit from robust Online segment revenues.

MGM Resorts, Boyd Gaming and PlayAGS are part of the Zacks Industry Outlook article.

Top Midday Stories: Fed's Preferred Inflation Reading Up in June; 3M's Adjusted Earnings Gain; DexCom Cuts 2024 Revenue Guidance; Bristol-Myers Squibb's Higher Results; WesBanco, Premier Financial to Merge

Apollo Global Management agreed to buy International Game Technology’s gaming and digital arm and Everi Holdings in a roughly $6.3 billion deal.

Everi, IGT's Gaming and Digital Business to Be Acquired by Apollo Global in $6.3 Billion Deal

Sirius XM, Charter Communications, and Warner Bros. Discovery have come under pressure. But investors shouldn’t count him out.

While not a mind-blowing move, it is good to see that the Liberty Broadband Corporation ( NASDAQ:LBRD.K ) share price...

Top Midday Stories: Fed's Preferred Inflation Reading Up in June; 3M's Adjusted Earnings Gain; DexCom Cuts 2024 Revenue Guidance; Bristol-Myers Squibb's Higher Results; WesBanco, Premier Financial to Merge

Apollo Global Management agreed to buy International Game Technology’s gaming and digital arm and Everi Holdings in a roughly $6.3 billion deal.

Everi, IGT's Gaming and Digital Business to Be Acquired by Apollo Global in $6.3 Billion Deal

Everi Holdings, International Game Technology Sign $6.30 Billion Acquisition Deal With Apollo Global Management Funds

(Reuters) -Private equity firm Apollo Funds will take International Game Technology's gaming and digital business and Everi Holdings private in an all-cash deal that values the combined business at $6.3 billion, the companies said on Friday. Shares of IGT jumped 20%, while casino platform provider Everi rose 40% in early trading. The deal is the latest sign of a resurgence in the private equity space following a period of dormancy due to high interest rates that had hindered debt financing for leveraged buyouts.

International Game Technology PLC (NYSE: IGT) ("IGT") and Everi Holdings Inc. (NYSE: EVRI) ("Everi") today announced that they have entered into definitive agreements whereby IGT's Gaming & Digital business ("IGT Gaming") and Everi will be simultaneously acquired by a newly formed holding company owned by funds managed by affiliates of Apollo Global Management, Inc. (NYSE: APO) ("Apollo") (the "Apollo Funds") in an all-cash transaction that values the acquired businesses at approximately $6.3 bi

Shares of casino gaming technology company Everi (NYSE:EVRI) jumped 42.2% in the morning session after the company announced it has agreed to a deal to be acquired alongside IGT's Gaming & Digital business by a newly formed holding company owned by funds managed by affiliates of Apollo Global Management, Inc. in an all-cash transaction. The deal values the acquired businesses at approximately $6.3 billion. To provide some context, on February 29, 2024, IGT and Everi agreed to a deal in which IGT

US Foods will promote Square's software and hardware solutions to its customers across the country.

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Herbalife (NYSE:HLF) and the rest of the personal care stocks fared in Q1.

AUSTIN, Texas, July 26, 2024--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced a new study published in the Journal of Clinical Oncology highlighting the utility of its personalized and tumor-informed molecular residual disease (MRD) test, Signatera, for surveillance in Merkel cell carcinoma (MCC). The full study can be found here.

Boyd Gaming's (BYD) second-quarter 2024 results benefit from robust Online segment revenues.

MGM Resorts, Boyd Gaming and PlayAGS are part of the Zacks Industry Outlook article.

Top Midday Stories: Fed's Preferred Inflation Reading Up in June; 3M's Adjusted Earnings Gain; DexCom Cuts 2024 Revenue Guidance; Bristol-Myers Squibb's Higher Results; WesBanco, Premier Financial to Merge

Apollo Global Management agreed to buy International Game Technology’s gaming and digital arm and Everi Holdings in a roughly $6.3 billion deal.

Everi, IGT's Gaming and Digital Business to Be Acquired by Apollo Global in $6.3 Billion Deal

Everi Holdings, International Game Technology Sign $6.30 Billion Acquisition Deal With Apollo Global Management Funds

(Reuters) -Private equity firm Apollo Funds will take International Game Technology's gaming and digital business and Everi Holdings private in an all-cash deal that values the combined business at $6.3 billion, the companies said on Friday. Shares of IGT jumped 20%, while casino platform provider Everi rose 40% in early trading. The deal is the latest sign of a resurgence in the private equity space following a period of dormancy due to high interest rates that had hindered debt financing for leveraged buyouts.

Sketchers' (SKX) Q2 earnings decline y/y. The company focuses on innovation and partnerships, aiming for $10 billion in annual sales by 2026.

RAHWAY, N.J., July 26, 2024--Merck Receives Positive EU CHMP Opinion for KEYTRUDA Plus Padcev as First-Line Treatment for Patients With Advanced Bladder Cancer

DexCom falls sharply after cutting its fiscal-year sales forecast, 3M and Bristol Myers surge after the companies post better-than-forecast earnings, and Biogen tumbles after European regulators reject its Alzheimer's treatment.

The Federal Reserve's preferred inflation gauge, the Personal Consumption Expenditures (PCE) index, showed prices rising at its slowest rate in over three years while core PCE data came largely in-line with expectations. Seana Smith and Jared Blikre help investors start the day off right, highlighting the biggest market stories this morning as the three major averages (^DJI, ^IXIC, ^GSPC) digest the June PCE print. Bank of America Securities head of US economics Michael Gapen joins the program to shine a light on how the Fed may be looking at the June PCE data, alongside other recent inflation prints, in terms of its interest rate cut strategy. Bernstein senior analyst Daniel Roeska also sits down with The Morning Brief team to cover the auto industry's earnings performance this week, including Tesla (TSLA) and Stellantis (STLA). Other top trending tickers on the Yahoo Finance platform include the 3M Company (MMM), Deckers Outdoor (DECK), DexCom (DXCM), Norfolk Southern (NSC), and Coursera (COUR). This post was written by Luke Carberry Mogan.

U.S. equities rose at midday as the inflation report favored by the Federal Reserve came in as expected, boosting optimism of interest-rate cuts this year.

Stocks that traded heavily or had substantial price changes on Friday: Bristol-Myers Squibb Co. (BMY), up $4.31 to $49.58. The biopharmaceutical company beat analysts' second-quarter earnings and revenue forecasts. Colgate-Palmolive Co. (CL), up $3.71 to $100.20.

DexCom's (DXCM) second-quarter 2024 earnings surpass expectations while revenues fall short. The Sensor segment and CGM system expansion drive growth. Shares fall.

Top Midday Stories: Fed's Preferred Inflation Reading Up in June; 3M's Adjusted Earnings Gain; DexCom Cuts 2024 Revenue Guidance; Bristol-Myers Squibb's Higher Results; WesBanco, Premier Financial to Merge

Shares of DexCom were spiraling after the medical device company surprised Wall Street with a steep cut to guidance, and grim news about its performance in the second quarter. DexCom stock slumped 40% to $64.70 in trading Friday and was on track for its worst daily percentage decline on record, according to Dow Jones Market Data. The stock slid last fall on fears around anti-obesity drugs, or GLP-1s—the company designs and sells continuous glucose monitors for diabetics—but that doesn’t appear to be dragging shares lower Friday.

Fortinet (FTNT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Impinj ( NASDAQ:PI ) Second Quarter 2024 Results Key Financial Results Revenue: US$102.5m (up 19% from 2Q 2023). Net...

Looking back on custom parts manufacturing stocks' Q1 earnings, we examine this quarter's best and worst performers, including Stratasys (NASDAQ:SSYS) and its peers.

The consensus price target hints at a 125.9% upside potential for uniQure (QURE). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Earnings Release: Wednesday, July 31, 2024, Before Market OpensConference Call and Webcast: Wednesday, July 31, 2024, at 8:30 a.m. ET MONACO, July 26, 2024 (GLOBE NEWSWIRE) -- Costamare Inc. (NYSE:CMRE), announced today that it will release its results for the second quarter ended June 30, 2024 before the market opens in New York on Wednesday, July 31, 2024. Conference Call Details: On Wednesday, July 31, 2024 at 8:30 a.m. ET, Costamare’s management team will hold a conference call to discuss th

DexCom falls sharply after cutting its fiscal-year sales forecast, 3M and Bristol Myers surge after the companies post better-than-forecast earnings, and Biogen tumbles after European regulators reject its Alzheimer's treatment.

The Federal Reserve's preferred inflation gauge, the Personal Consumption Expenditures (PCE) index, showed prices rising at its slowest rate in over three years while core PCE data came largely in-line with expectations. Seana Smith and Jared Blikre help investors start the day off right, highlighting the biggest market stories this morning as the three major averages (^DJI, ^IXIC, ^GSPC) digest the June PCE print. Bank of America Securities head of US economics Michael Gapen joins the program to shine a light on how the Fed may be looking at the June PCE data, alongside other recent inflation prints, in terms of its interest rate cut strategy. Bernstein senior analyst Daniel Roeska also sits down with The Morning Brief team to cover the auto industry's earnings performance this week, including Tesla (TSLA) and Stellantis (STLA). Other top trending tickers on the Yahoo Finance platform include the 3M Company (MMM), Deckers Outdoor (DECK), DexCom (DXCM), Norfolk Southern (NSC), and Coursera (COUR). This post was written by Luke Carberry Mogan.

U.S. equities rose at midday as the inflation report favored by the Federal Reserve came in as expected, boosting optimism of interest-rate cuts this year.

Stocks that traded heavily or had substantial price changes on Friday: Bristol-Myers Squibb Co. (BMY), up $4.31 to $49.58. The biopharmaceutical company beat analysts' second-quarter earnings and revenue forecasts. Colgate-Palmolive Co. (CL), up $3.71 to $100.20.

DexCom's (DXCM) second-quarter 2024 earnings surpass expectations while revenues fall short. The Sensor segment and CGM system expansion drive growth. Shares fall.

Top Midday Stories: Fed's Preferred Inflation Reading Up in June; 3M's Adjusted Earnings Gain; DexCom Cuts 2024 Revenue Guidance; Bristol-Myers Squibb's Higher Results; WesBanco, Premier Financial to Merge

Shares of DexCom were spiraling after the medical device company surprised Wall Street with a steep cut to guidance, and grim news about its performance in the second quarter. DexCom stock slumped 40% to $64.70 in trading Friday and was on track for its worst daily percentage decline on record, according to Dow Jones Market Data. The stock slid last fall on fears around anti-obesity drugs, or GLP-1s—the company designs and sells continuous glucose monitors for diabetics—but that doesn’t appear to be dragging shares lower Friday.

Q2 2024 Zynex Inc Earnings Call

Perrigo (PRGO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Key Insights Given the large stake in the stock by institutions, Tactile Systems Technology's stock price might be...

Inari Medical, Inc. ( NASDAQ:NARI ), might not be a large cap stock, but it saw a significant share price rise of 49...

Utah Medical (UTMD) reports a 19.2% revenue decline in 2Q24, with EPS down 15.3% due to lower sales to major customers. Despite this, profit margins remained stable.

Integer Holdings' (ITGR) second-quarter results reflect robust Medical Sales, along with strength in all the product lines.

Shares of DexCom, which makes monitoring devices for diabetes patients, tumbled 40% in early trading after it cut sales guidance. **That put the stock on pace for its biggest one-day decline ever.** DexCom’s chief executive partially attributed the revenue shortfall to being “short a large number of new patients,” compared to what the company had expected. DexCom cut its full-year revenue outlook to $4 billion to $4.05 billion, from $4.2 billion to $4.35 billion.